Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Freuchet

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|September 16, 2024
Inflammation and heterogeneity in synucleinopathiesAntoine Freuchet, Anaëlle Pinçon, Alessandro Sette, et al.
Journal of Leukocyte Biology|February 18, 2021
IL-34 and CSF-1, deciphering similarities and differences at steady state and in diseasesAntoine Freuchet, Apolline Salama, Séverine Remy, et al.
Frontiers in Immunology|August 28, 2020
IL-34 Actions on FOXP3<sup>+</sup> Tregs and CD14<sup>+</sup> Monocytes Control Human Graft RejectionSéverine Bézie, Antoine Freuchet, Céline Sérazin, et al.
NPJ Parkinson'S Disease|May 14, 2025
Differential memory enrichment of cytotoxic CD4 T cells in Parkinson's disease patients reactive to α-synucleinAntoine Freuchet, Emil Johansson, April Frazier, et al.
Human Immunology|March 3, 2024
Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19Gregory P Williams, Esther Dawen Yu, Kendra Shapiro, et al.
Nature Immunology|August 10, 2023
Identification of human exT<sub>reg</sub> cells as CD16<sup>+</sup>CD56<sup>+</sup> cytotoxic CD4<sup>+</sup> T cellsAntoine Freuchet, Payel Roy, Sujit Silas Armstrong, et al.
Clinical and Translational Medicine|August 28, 2022
IL-34 deficiency impairs FOXP3<sup>+</sup> Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasisAntoine Freuchet, Apolline Salama, Séverine Bézie, et al.
The Journal of Clinical Investigation|December 17, 2024
PINK1 is a target of T cell responses in Parkinson's diseaseGregory P Williams, Antoine Freuchet, Tanner Michaelis, et al.
Blood Advances|June 9, 2020
Transient antibody targeting of CD45RC inhibits the development of graft-versus-host diseaseLaetitia Boucault, Maria-Dolores Lopez Robles, Allan Thiolat, et al.
International Journal of Molecular Sciences|September 9, 2022
Sex Differences in Coronary Artery Disease and Diabetes Revealed by scRNA-Seq and CITE-Seq of Human CD4+ T CellsRyosuke Saigusa, Jenifer Vallejo, Rishab Gulati, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|September 16, 2024
Inflammation and heterogeneity in synucleinopathiesAntoine Freuchet, Anaëlle Pinçon, Alessandro Sette, et al.
Journal of Leukocyte Biology|February 18, 2021
IL-34 and CSF-1, deciphering similarities and differences at steady state and in diseasesAntoine Freuchet, Apolline Salama, Séverine Remy, et al.
Frontiers in Immunology|August 28, 2020
IL-34 Actions on FOXP3<sup>+</sup> Tregs and CD14<sup>+</sup> Monocytes Control Human Graft RejectionSéverine Bézie, Antoine Freuchet, Céline Sérazin, et al.
NPJ Parkinson'S Disease|May 14, 2025
Differential memory enrichment of cytotoxic CD4 T cells in Parkinson's disease patients reactive to α-synucleinAntoine Freuchet, Emil Johansson, April Frazier, et al.
Human Immunology|March 3, 2024
Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19Gregory P Williams, Esther Dawen Yu, Kendra Shapiro, et al.
Nature Immunology|August 10, 2023
Identification of human exT<sub>reg</sub> cells as CD16<sup>+</sup>CD56<sup>+</sup> cytotoxic CD4<sup>+</sup> T cellsAntoine Freuchet, Payel Roy, Sujit Silas Armstrong, et al.
Clinical and Translational Medicine|August 28, 2022
IL-34 deficiency impairs FOXP3<sup>+</sup> Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasisAntoine Freuchet, Apolline Salama, Séverine Bézie, et al.
The Journal of Clinical Investigation|December 17, 2024
PINK1 is a target of T cell responses in Parkinson's diseaseGregory P Williams, Antoine Freuchet, Tanner Michaelis, et al.
Blood Advances|June 9, 2020
Transient antibody targeting of CD45RC inhibits the development of graft-versus-host diseaseLaetitia Boucault, Maria-Dolores Lopez Robles, Allan Thiolat, et al.
International Journal of Molecular Sciences|September 9, 2022
Sex Differences in Coronary Artery Disease and Diabetes Revealed by scRNA-Seq and CITE-Seq of Human CD4+ T CellsRyosuke Saigusa, Jenifer Vallejo, Rishab Gulati, et al.
Pageof 2